Formulary, restricted to psychiatrists for use in patients unresponsive to other oral antipsychotics.
Inpatients should use home supply if available. The 50 mg-20 mg and 100 mg-20 mg dosage forms will be stocked for inpatient use. For inpatients whose home supply is unavailable, the 125 mg-30 mg dose will be automatically interchanged to the 100 mg-20 mg dose.
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
xanomeline-trospium (Cobenfy)
xanomeline 125 mg-trospium 30 mg oral capsule
Only interchange for inpatients whose home supply is unavailable
Formulary, restricted to psychiatrists for use in patients unresponsive to other oral antipsychotics.
Inpatients should use home supply if available. The 50 mg-20 mg and 100 mg-20 mg dosage forms will be stocked for inpatient use. For inpatients whose home supply is unavailable, the 125 mg-30 mg dose will be automatically interchanged to the 100 mg-20 mg dose.
ORDERED FORMULATION
THERAPEUTIC INTERCHANGE
xanomeline-trospium (Cobenfy)
xanomeline-trospium (Cobenfy)
Reviewed: February 2025
Xanomeline-trospium (Cobenfy) Spotlight